Log in

TapImmune Price Target & Analyst Ratings (NASDAQ:MRKR)

$4.56
+0.18 (+4.11 %)
(As of 10/14/2019 07:31 AM ET)
Today's Range
$4.33
Now: $4.56
$4.69
50-Day Range
$4.40
MA: $5.29
$6.19
52-Week Range
$3.97
Now: $4.56
$10.25
Volume161,508 shs
Average Volume244,649 shs
Market Capitalization$208.26 million
P/E RatioN/A
Dividend YieldN/A
Beta0.12

Analyst Ratings

TapImmune (NASDAQ:MRKR) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for TapImmune in the last 12 months. Their average twelve-month price target is $10.90, suggesting that the stock has a possible upside of 139.08%. The high price target for MRKR is $16.00 and the low price target for MRKR is $6.22. There are currently 5 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.173.173.173.25
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $10.90$10.90$10.90$9.84
Price Target Upside: 139.08% upside142.27% upside38.53% upside63.13% upside

TapImmune (NASDAQ:MRKR) Consensus Price Target History

TapImmune (NASDAQ:MRKR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/13/2019NomuraReiterated RatingBuy$16.00High
7/21/2019Janney Montgomery ScottReiterated RatingBuyN/A
7/3/2019OppenheimerInitiated CoverageOutperform$15.00 ➝ $15.00Low
5/30/2019Roth CapitalInitiated CoverageBuy$10.00 ➝ $10.00High
3/29/2019WBB SecuritiesUpgradeBuy ➝ Strong-Buy$7.29High
12/3/2018Piper Jaffray CompaniesUpgradeNeutral ➝ OverweightHigh
(Data available from 10/14/2017 forward)
This page was last updated on 10/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel